News

Study: Lack of trust less of a barrier to clinical trial participation

Wednesday, September 20, 2017

Significantly fewer African-Americans, Hispanics, Asians and non-Hispanic whites say “lack of trust” is a reason why individuals do not participate in clinical trials, indicating a more favorable perception of this research. In a recent public opinion survey commissioned by Research!America, the percentage of respondents citing ‘lack of trust’ as a reason declined by as much as 15% among minority groups and the population overall, compared to the results of a 2013 survey—50% of African-Americans (11% decrease), 45% of Asians (6% decrease), 43% of Hispanics (9% decrease) and 39% of non-Hispanic whites (15% decrease).

[Read More]

CRF Health opens Romania office

Wednesday, September 20, 2017

CRF Health, a global provider of patient-centered eSource technology and service solutions for the life sciences industry, will officially open their Romania office and welcome to the helm a new VP of Global Services, Adina Tapalaga.

[Read More]

Great Gift moves to Innovation Quarter

Tuesday, September 19, 2017

Jennifer Byrne is the founder of Greater Gift, a nonprofit organization that facilitates the donation of vaccines in honor of clinical research participants. Seeing students walk by every day on the way to class, she envisions the impact that these future doctors, physician assistants and certified nurses can have on their patients—not only through patient care, but also through promoting clinical research.

[Read More]

Catalent to acquire Cook Pharmica for $950M

Tuesday, September 19, 2017

Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has reached an agreement to acquire Bloomington, Indiana-based Cook Pharmica, an integrated provider of drug substance and drug product manufacturing and related services. The purchase price is $950 million, with $750 million to be paid at closing and the balance to be paid in equal installments, without interest, on each of the next four anniversaries of the closing. The acquisition will strengthen Catalent’s position as a leader in the rapidly growing area of biologics development and analytical services, manufacturing, and finished product supply.

[Read More]

Aequus, Ehave collaborate on bioinformatics platform

Monday, September 18, 2017

Aequus Pharmaceuticals, a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, and Ehave, a healthcare bioinformatics company whose platform efficiently captures, integrates and delivers high-quality clinical data and treatment tools, have entered into a collaboration whereby Aequus will gain access to Ehave’s bioinformatics platform for use in Aequus’ anticipated clinical trials for its portfolio products, with an initial focus in neurology.

[Read More]